A patient with Beta-Propeller Protein-Associated Neurodegeneration: a new missense mutation of the WDR45 gene
Ivanova, Anastasia, Kulikova, Sviatlana, Sivitskaya, Larysa, Danilenko, Nina, Davydenko, Oleg
AHEAD OF PRINT
Epilepsy and autism: How does age at seizure onset factor in?
Braun, Claude M.J., Elie-Fortier, Jonathan
Epilepsy knowledge, attitudes, behaviors, and associated factors among primary, post-primary, and secondary school teachers in Ouagadougou (Burkina Faso)
Dabilgou, Alfred Anselme, Dravé, Alassane, Kyelem, Julie Marie Adeline, Meda, Naobar, Napon, Christian, Karfo, Kapouné, Kaboré, Jean
Levetiracetam as second-line treatment of status epilepticus – which dose should be applied?
Rösche, Johannes, Schade, Bernd
Volume 29 (2021): Issue 1 (July 2021)
Clinical characteristics of forced normalization and alternative psychosis with special consideration of the new anticonvulsants
Fröscher, Walter, Faust, Volker, Steinert, Tilman
mHealth tools in the management of epilepsy
Blek, Natasza, Zwoliński, Piotr
Pharmacoresistant epilepsy associated with mutations in the KCNB1 and RELN genes. A case report
Katerelos, Adamantios, Zagkos, Nikolaos, Alexopoulou, Dimitra, Mouskou, Stella, Korona, Anastasia, Manolakos, Emmanouil
A position paper on breastfeeding by women with epilepsy – working group report
Jędrzejczak, Joanna, Wilińska, Maria, Kamińska, Ewa, Lauterbach, Ryszard, Helwich, Ewa, Jackowska, Teresa, Nagańska, Ewa, Jacyna, Natalia, Majkowska-Zwolińska, Beata
Volume 28 (2020): Issue 1 (December 2020)
Treatment with lacosamide or levetiracetam in patients with renal replacement therapy. What is really known?
Cuhls, Maya, Bösel, Julian, Rösche, Johannes